Use of mini-monoka stents for punctal/canalicular stenosis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 22241928.
- Also identified by DOI 10.1136/bjophthalmol-2011-300670.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Proximal lacrimal system stenosis may cause debilitating epiphora and recurrent ocular infections. Mini-monoka stents are primarily used in the management of canalicular lacerations. Evidence regarding their use to treat punctal/canalicular stenosis is sparse. Compared with dacryocystorhinostomy, a punctocanaliculoplasty with mini-monoka stenting is quicker, less invasive with reduced postoperative complications/recovery time. To assess the effectiveness of mini-monoka punctocanaliculoplasty for treatment of punctal/canalicular stenosis. A retrospective case note analysis was performed on 77 consecutive patients (123 eyes). 73% of eyes had punctal stenosis, 72% had canalicular stenosis; 46% had a combination of the above. 20% had some degree of lid laxity and 29% had nasolacrimal duct stenosis. 101 eyes (82%) had significant improvement in symptoms and were discharged without further intervention. Excluding the patients with structural comorbidity the success rate improved to 88%. Mini-monoka punctocanaliculoplasty is an effective, safe, simple and relatively non-invasive treatment strategy for the management of epiphora secondary to punctal and/or canalicular stenosis.
Medical subject headings
- Dacryocystorhinostomy
- Eyelids
- Intubation
- Nasolacrimal Duct
- Stents